SCHEMBL25817967

SCHEMBL25817967

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5ccc6ccc(-c7ccccc7)cc6c5)c4)nc(-c4ccc5c(c4)sc4cccc(-c6ccccc6)c45)n3)cc2)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
LIMK1 P53667 3/20 0.35
PIK3CA P42336 1/20 0.35
PI4KA P42356 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
F9 P00740 3/20 0.34
HSD17B1 P14061 1/20 0.33
HSD17B2 P37059 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
S1PR5 Q9H228 3/20 0.32
S1PR4 O95977 2/20 0.32
MEN1 O00255 3/20 0.32
ALDH1A1 P00352 3/20 0.32
KMT2A Q03164 3/20 0.32
KDM4E B2RXH2 2/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26271394 0.96 KDM4E (0.36) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL26271398 0.95 KDM4E (0.37) ESR1ESR2LIMK1PIK3CAPI4KA
SCHEMBL24523664 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL24523521 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL25851944 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL24523457 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL24523666 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL24523348 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL24523647 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9
SCHEMBL25645752 0.95 LIMK1 (0.38) LIMK1PIK3CAPI4KAPI4KBF9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ESR1 2/4885ESR2 14/4885LIMK1 905/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ESR1 2/4885ESR2 14/4885LIMK1 905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.